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Several reports using recently developed physicochemical and imaging techniques have provided 
experimental evidence for the existence of dimers of Ras proteins, which was first postulated more than 25 
years ago. These data have sparked renewed interest in the potential physiological and pathological 
importance of homoor heterodimerization of Ras proteins. Understanding the structural and functional 
properties of Ras dimers should provide mechanistic explanations for unanswered questions regarding the 
involvement of Ras proteins in signaling pathways that contribute to both normal physiology and oncogenic 
processes. Furthermore, this knowledge should enable the development of new drugs targeting Ras 
proteins. 
 
The Ras family of guanosine triphosphatases (GTPases) comprises three “canonical” 
isoforms (H-Ras, N-Ras, and K-Ras), which are associated with signal initiation at the 
plasma membrane. The different Ras isoforms appear to be functionally specific and 
are variably expressed in different cell lineages and tissues. Ras dimers first appeared 
in the scientific literature in a 1988 report describing the recovery of Ras proteins with a 
molecular weight indicative of homo-oligomers, possibly dimers, in radiation 
inactivation experiments performed on H-Ras–transformed cells or purified Ras 
proteins. That initial description of Ras dimers was followed by the characterization of 
the crystal structure of purified Ras proteins bound to guanosine diphosphate (GDP) or 
guanosine triphosphate (GTP). The initial descriptions of Ras crystals offered a 
structural basis for understanding the known biochemical and regulatory properties of 
normal and oncogenic Ras proteins without invoking the existence of dimers, thus 
contributing to the oversight or dismissal of the concept of functional Ras dimers at that 
time. More than a decade later, Ras dimers were mentioned again, this time in the 
context of the dimerization of kinases of the Raf family, which are activated by Ras 
proteins and are the first kinases in the three-tiered mitogen-activated protein kinase 
(MAPK) cascade. Crystal structures of B-Raf revealed amino acid residues conserved 
in all Raf proteins that mediate direct, side-toside dimer formation. Furthermore, Raf 
dimers play a critical role in physiological, Ras-dependent activation of normal Raf 
proteins and in the pathological activity of various cancer-associated Raf mutants. 
Whereas dimerization has little impact on the transforming ability of B-Raf mutants with 
high kinase activity (B-Raf V600E), the ability to dimerize profoundly increases the 
transforming activity of other Raf mutants with intermediate or impaired kinase activity. 
Raf dimers are also important for the therapeutic response and mechanism of 
resistance to various inhibitors of the kinase activity of Raf. For example, ATP-
competitive inhibitors of the kinase activity of B-Raf promote B-Raf homo- and 
heterodimerization, which provides a conceptual framework for understanding the 
paradoxical activation of downstream signaling in cells that exhibit resistance to these 
inhibitors and suggests that blocking Raf dimerization may be therapeutically 
beneficial. Given that Raf signaling is influenced by dimerization and that Ras proteins 
are the GTPases that activate these kinases, there is renewed interest in investigating 
the potential functional importance of Ras dimers. Artificially enforced 
homodimerization of H-Ras or KRas activates C-Raf (Raf-1), but whether Ras 
dimerization occurred natively or in vivo was not explored in this study. Several recent 
reports using sophisticated physicochemical and imaging techniques— including total 
reflectance Fourier transform infrared spectroscopy (AT-FTIR), Förster resonance 
energy transfer (FRET), fluorescence correlation spectroscopy (FCS), timeresolved 
fluorescence anisotropy (TRFA), and single-molecule tracking (SMT)—have produced 
experimental evidence for the existence of N-Ras, H-Ras, or K-Ras dimers under 
various experimental conditions. Güldenhaupt et al. noted that Ras forms dimers in at 
least 50 of the 71 published x-ray structural models and showed that lipidated N-Ras 
proteins form dimers in artificial membranes using AT-FTIR, biomolecular simulations, 
and FRET.  
The authors propose that amino acid residues located in helices α4 and α5 and the 
loop between strands β2 and β3 of N-Ras form a stable dimerization interface, and 
these residues are conserved in H-Ras and K-Ras proteins. Lin et al. characterized 
various H-Ras mutants anchored to supported lipid bilayers using a combination of 
FCS and TRFA and confirmed the existence of HRas clusters. Photon-counting 
histogram analysis and SMT indicated that the H-Ras clusters were dimers, not higher-
order oligomers. Interestingly, a Y64A point mutation in the loop between strand β3 and 
helix α2 abolished dimer formation, suggesting that this region is either part of, or 
allosterically coupled to, the dimer interface. Similar demonstrations of dimers of K-
Ras, the Ras isoform most frequently activated in human tumors, have not been 
published but seem likely given the structural and sequence similarities of this protein 
with its related family members. Indeed, “blocking the formation of self-binding and 
other K-Ras complexes” is a specific goal listed in the National Cancer Institute’s Ras 
initiative to overcome the inability to successfully target Ras therapeutically. In addition 
to the three canonical Ras proteins, there are several families of Ras-related proteins. 
Although homo- and heterodimers of Ras-related GTPases drive specific cellular 
responses in yeast, such as bud-site selection and polarity establishment, experimental 
confirmation of the functional importance of dimers of the Ras family in mammals is still 
absent. If their functional relevance is confirmed, it will be important to ascertain 
whether such dimers are homo- or heterodimers, because the latter greatly increases 
the number of possible functional complexes and regulatory complexity of Ras-
mediated signaling. Ras dimerization may also be important for the pathology of 
oncogenic Ras signals, which could offer molecular explanations for unresolved 
controversies, such as the contribution of homozygous or heterozygous Ras oncogenic 
mutations for cancer development and progression, and whether wild-type Ras 
contributes to oncogenic Ras–driven tumorogenicity. Dimerization might also catalyze 
nanoclustering of membrane-associated Ras. These nanoclusters are transient (<1 s 
lifetime), small (<20 nm in diameter), and estimated to contain ~6 to 7 Ras molecules 
(Fig. 1). The spatiotemporal dynamics of these Ras nanoclusters  are  essential  for  
high-fidel- ity Ras-dependent signaling through the MAPK cascade. Small molecules 
that inhibit Ras by targeting an allosteric bind- ing pocket and other drugs that bind 
the Ras-Sos complex disrupt downstream Ras signaling. Because allosteric inter- 
actions are clearly involved in establishing the drug-binding pockets targeted in these 
approaches, an interesting possibility is that Ras dimers, or even Ras nanoclusters, 
might become valid therapeutic targets for new drugs aimed at the interface between 
subunits in Ras dimers. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Dynamic Ras clustering in the plasma membrane.  
(A) Ras monomers and dimers viewed from the intracellular side of the plasma membrane. The inset 
shows a Ras dimer based on the crystal structure PDB ID 4LRW.  
(B) Dimers may contribute to the formation of Ras nanoclusters, which are membrane nanodomains that 
transiently form and contain several membrane-bound Ras units. Whether these units are composed of 
complexes of dimers, complexes of dimers and monomers, or other high-order oligomers is unknown 
 
